| |
| |
|
| Insider
Information: |
Santini Gino |
| Relationship: |
Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
172,151 |
|
|
Indirect Shares
|
3,249 |
|
|
| Direct
Value |
$81,102,739 |
|
|
|
Indirect Value
|
$2,648,130 |
|
|
| Total
Shares |
175,400 |
|
|
| Total
Value |
$83,750,869 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
Sr.VP, Corp. Strategy ... |
2009-12-07 |
96,495 |
2009-12-07 |
3,249 |
Premium* |
|
|
AMAG Pharmaceuticals Inc |
AMAG |
Director |
2020-11-16 |
0 |
2013-05-23 |
0 |
Premium* |
|
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2024-05-16 |
75,656 |
|
0 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
83 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2020-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(41,473) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-10-06 |
4 |
D |
$116.50 |
$2,173,308 |
I/I |
(18,655) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-10-06 |
4 |
D |
$116.50 |
$11,761,724 |
D/D |
(100,959) |
0 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
• – – |
2004-08-05 |
5 |
GD |
$0.00 |
$0 |
I/I |
344 |
3,738 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2016-05-06 |
4 |
D |
$13.41 |
$19,015 |
I/I |
(1,418) |
3,840 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
• – – |
2004-08-05 |
5 |
GA |
$0.00 |
$0 |
I/I |
2,478 |
4,082 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2013-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,300 |
5,075 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2016-05-06 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,258 |
5,258 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
• – – |
2005-10-07 |
5 |
GD |
$0.00 |
$0 |
I/I |
410 |
5,494 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
• – – |
2005-10-07 |
5 |
GA |
$0.00 |
$0 |
I/I |
2,986 |
5,904 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President, US Operations Offic |
• – – |
2004-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,576 |
|
- |
|
| LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
• – – |
2006-06-09 |
5 |
GA |
$0.00 |
$0 |
I/I |
2,778 |
7,810 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
• – – |
2007-05-31 |
5 |
GA |
$0.00 |
$0 |
I/I |
843 |
8,653 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2014-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
8,875 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
• – – |
2007-06-04 |
5 |
GA |
$0.00 |
$0 |
I/I |
848 |
9,501 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
• – – |
2007-06-05 |
5 |
GA |
$0.00 |
$0 |
I/I |
339 |
9,840 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,322 |
10,197 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2017-05-03 |
4 |
D |
$15.12 |
$82,812 |
I/I |
(5,477) |
12,316 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & BD |
• – – |
2008-02-11 |
5 |
GA |
$0.00 |
$0 |
I/I |
2,548 |
12,388 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2016-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,768 |
14,965 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & BD |
• – – |
2009-05-05 |
5 |
GA |
$0.00 |
$0 |
I/I |
5,259 |
16,145 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2017-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
13,953 |
17,793 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,545 |
19,510 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2018-05-03 |
4 |
D |
$13.87 |
$76,521 |
I/I |
(5,517) |
20,853 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2018-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,578 |
23,088 |
0 |
- |
|
83 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
